Luca Boldrini, Chair of the ESTRO Education Council EDC and Director of the MR-guided External Beam Radiotherapy Unit at Agostino Gemelli University Hospital Foundation IRCCS, shared a post on LinkedIn:
“Excited to share our latest editorial in IJROBP The Red Journal:
‘Innovative Targets, New Technologies, Same Tenacity: Radiation Therapy’s Evolving Role in Pancreatic Cancer.’
We discuss emerging evidence from key prospective trials shaping locoregional and systemic strategies in PDAC.
From oligometastatic disease to neoadjuvant approaches and novel modalities like TTFields, the landscape is evolving fast.
Patient selection, hashtag#biology-driven stratification, and multidisciplinary integration remain central.
Grateful to the co-authors and the GI editorial team. Looking forward to the next steps in this field!”
Title: Innovative Targets, New Technologies, Same Tenacity: Radiation Therapy’s Evolving Role in Pancreatic Cancer
Authors: Krishan R Jethwa, Katelyn Atkins, Luca Boldrini, Jonathan B Ashman, Aisling Barry, Eric D Miller, Randa Tao, Michael D Chuong
Read the full article on Pubmed.
Other articles featuring Luca Boldrini on OncoDaily.